Upper leg conduction time distinguishes demyelinating neuropathies

Muscle and Nerve

Volumn 43, Issue 4, 2011, Pages 518-530

  Maccabee, Paul J ^a   Eberle, Larry P ^a   Stein, Ian A G ^a   Willer, Justin A ^a   Lipitz, Mark E ^a   Kula, Roger W ^a   Marx, Tatiana ^a   Muntean, Eugeniu V ^a   Amassian, Vahe E ^a  

^a Downstate Health Sciences University   (United States)

Author keywords

Cauda equina conduction time; Demyelinating neuropathy; Distal cauda equina latency; Neuromagnetic; Upper leg conduction time

Indexed keywords

ACUTE DISEASE; ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; AXONAL NEUROPATHY; CAUDA EQUINA; CHRONIC DISEASE; DEMYELINATING NEUROPATHY; DIABETIC NEUROPATHY; FEMALE; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; LUMBOSACRAL RADICULOPATHY; MAJOR CLINICAL STUDY; MALE; MUSCLE ACTION POTENTIAL; NERVE CONDUCTION; NERVE STIMULATION; NEUROPATHY; PERIPHERAL NERVE; POLYNEUROPATHY; PRIORITY JOURNAL; RADICULOPATHY; TIBIAL NERVE; TIBIALIS ANTERIOR MUSCLE; VASTUS MEDIALIS MUSCLE; ADOLESCENT; COMPARATIVE STUDY; DEMYELINATING DISEASES; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; POLYNEUROPATHIES; THIGH; TIME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; DEMYELINATING DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEURAL CONDUCTION; POLYNEUROPATHIES; THIGH; TIME FACTORS; YOUNG ADULT;

EID: 79953043037     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.21909     Document Type: Article

References (71)

1. Asbury AK, Arnason BG, Adams RD. The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis. Medicine (Baltimore) 1969;48:173-215.
2. Dyck PJ, Prineas J, Pollard J. Chronic inflammatory demyelinating polyradiculopathy. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Podulso JF, editors. Peripheral neuropathy. Vol. 2. Philadelphia: W.B. Saunders; 1993. p 1498-1517.
3. Honavar M, Tharakan JKJ, Hughes RAC, Leibowitz S, Winer JB. A clinicopathological study of the Guillain-Barré syndrome. Brain 1991;114:1245-1269.
4. Prineas JW. Pathology of the Guillain-Barré syndrome. Ann Neurol 1981;9(suppl):6-19.
5. Prineas JW, McLeod JG. Chronic relapsing polyneuritis. J Neurol Sci 1976;27:427-458.
6. Ertekin C, Nejat RS, Sirin H, Selcuki D, Arac N, Ertas M, et al. Comparison of magnetic coil stimulation and needle electrical stimulation in the diagnosis of lumbosacral radiculopathy. Clin Neurol Neurosurg 1994;96:124-129. (Pubitemid 24169440)
7. MacLean IC. Spinal nerve stimulation. Phys Med Rehabil Clin N Am 1994;5:509-529.
8. Maertens de Noordhout A, Rothwell JC, Thompson PD, Day BL, Marsden CD. Percutaneous electrical stimulation of lumbosacral roots in man. J Neurol Neurosurg Psychiatry 1988;51:174-181. (Pubitemid 18055121)
9. Menkes DL, Hood DC, Ballesteros RA, Williams DA. Root stimulation improves the detection of acquired demyelinating polyneuropathies. Muscle Nerve 1998;21:298-308. (Pubitemid 28096039)
10. Mills KR, Murray NM. Electrical stimulation over the human vertebral column: which neural elements are excited? Electroencephalogr Clin Neurophysiol 1986;63:582-589.
11. Swash M, Snooks SJ. Slowed motor conduction in lumbosacral nerve roots in cauda equina lesions: a new diagnostic technique. J Neurol Neurosurg Psychiatry 1986;49:808-816. (Pubitemid 16100419)
12. Britton TC, Myer BU, Herdmann J, Benecke R. Clinical use of the magnetic stimulator in the investigation of peripheral conduction time. Muscle Nerve 1990;13:390-406.
13. Chokroverty S, Sachdeo R, Dilullo J, Duvoisin RC. Magnetic stimulation in the diagnosis of lumbosacral radiculopathy. J Neurol Neurosurg Psychiatry 1989;52:767-772. (Pubitemid 19165644)
14. Chokroverty S, Flynn D, Picone MA, Chokroverty M, Belsh J. Magnetic coil stimulation of the human lumbosacral vertebral column: site of stimulation and clinical application. Electroencephalogr Clin Neurophysiol 1993;89:54-60. (Pubitemid 23051300)
15. MacDonell RA, Cros D, Shahani BT. Lumbosacral nerve root stimulation comparing electrical with surface magnetic coil techniques. Muscle Nerve 1992;15:885-890.
16. Ugawa Y, Rothwell JC, Day BL, Thompson PD, Marsden CD. Magnetic stimulation over the spinal enlargements. J Neurol Neurosurg Psychiatry 1989;52:1025-1032. (Pubitemid 19232780)
17. Matsumoto H, Octaviana F, Hanajima R, Terao Y, Yugeta A, et al. Magnetic lumbosacral motor root stimulation with a flat, large round coil. Clin Neurophysiol 2009;120:770-775.
18. Maccabee PJ, Lipitz ME, Desudchit T, Golub RW, Nitti VW, Bania JP, et al. A new method using neuromagnetic stimulation to measure conduction time within the cauda equina. Electromyogr Motor Control Electroencephalogr Clin Neurophysiol 1996;101:153-166.
19. Maccabee PJ, Amassian VE, Eberle LP, Cracco RQ. Magnetic coil stimulation of straight and bent amphibian and mammalian peripheral nerve in vitro: locus of excitation. J Physiol Lond 1993;460:201-219. (Pubitemid 23058046)
20. Maccabee PJ, Lipitz ME, Desudchit T, Amassian VE, Willer JA, Cracco RQ, et al. Patterns of cauda equina, limb and terminal segment conduction time abnormalities in demyelinating and axonal neuropathies. Neurology 1996;47:296.
21. Maccabee PJ, Stein IAG, Eberle LP, Willer JA, Amassian VE. Detection of demyelinating neuropathy using cauda equina nerve conduction studies. Ann Neurol 2006;60(suppl 10):S93-S93.
22. Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisted: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:293-299.
23. England JD, Gronseth GS, Franklin G, Miller RG, Asbury AK, et al. Distal symmetric polyneuropathy: a definition for clinical research. Neurology 2005;64:199-207.
24. Van Doorn PA, Ruts L, Jacobs BC. Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome. Lancet Neurol 2008;7:939-950.
25. Albers JW, Donofrio PD, McGonagle TK. Sequential electrodiagnostic abnormalities in acute inflammatory demyelinating polyneuropathy. Muscle Nerve 1985;8:528-539.
26. Alam TA, Chaudhry V, Cornblath DR. Electrophysiological studies in the Guillain-Barré syndrome: distinguishing subtypes by published criteria. Muscle Nerve 1998;21:1275-1279. (Pubitemid 28406709)
27. Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force.Research criteria for diagnosis chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology 1991;41:617-618.
28. Hughes R, Bensa S, Willison HJ, Van den Bergh P, Comi G, Illa I, et al. Randomized controlled trial of intravenous immunoglobulin versus prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 2001;50:195-201. (Pubitemid 32738144)
29. Saperstein DS, Katz JS, Amato AA, Barohn RJ. Clinical spectrum of chronic acquired demyelinating polyneuropathies. Muscle Nerve 2001;24:311-324. (Pubitemid 32172706)
30. Nicholas G, Maisonobe T, Le Forestier N, Léger JM, Bouche P. Proposed revised electrophysiological criteria for chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 2002;25:26-30. (Pubitemid 34019731)
31. Van den Bergh PYK, Pieret F. Electrodiagnostic criteria for acute and chronic demyelinating polyradiculopathy. Muscle Nerve 2004;29:565-574. (Pubitemid 38451348)
32. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyneuropathy. Eur J Neurol 2006;13:326-332.
33. Thaisetthawatkul P, Logigian EL, Herrmann DN. Dispersion of the distal compound muscle action potential as a diagnostic criterion for chronic inflammatory demyelinating polyneuropathy. Neurology 2002;59:1526-1532. (Pubitemid 35387056)
34. Dyck PJ, O'Brien PC, Oviatt KF, Dinapoli RP, Daube JR, et al. Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment. Ann Neurol 1982;11;136-141. (Pubitemid 12162978)
35. Barohn RJ, Kissel JT, Warmolts JR, Mendell JR. Chronic inflammatory demyelinating polyradiculoneuropathy. Arch Neurol 1989;46:878-884.
36. Koller H, Kieseier BC, Jander S, Hartung HP. Chronic inflammatory demyelinating polyneuropathy. N Engl J Med 2005;352:1343-1356.
37. Lewis R. Chronic inflammatory demyelinating polyneuropathy. Neurol Clin 2007;25:71-87. (Pubitemid 46283311)
38. Sander HW, Latov N. Research criteria for defining patients with CIDP. Neurology 2003;60(suppl 3):S8-15.
39. Dispenzieri A, Kyle RA, Lacy MQ, Rajkumar SV, Therneau TM, et al. POEMS syndrome: definitions and long-term outcome. Blood 2003;101:2496-2506. (Pubitemid 36857604)
40. Maccabee PJ, Amassian VE, Eberle LP, Rudell AP, Cracco RQ, Lai KS, et al. Measurement of the electric field induced into inhomogeneous volume conductors by magnetic coils: application to human spinal neurogeometry. Electroencephalogr Clin Neurophysiol 1991;81:224-237.
41. Mills KR, McLeod C, Sheffy J, Loh L. The optimal current direction for excitation of human cervical motor roots with a double coil magnetic stimulator. Electroencephalogr Clin Neurophysiol 1993;89:138-144. (Pubitemid 23131053)
42. Maccabee PJ, Nagarajan SS, Amassian VE, Durand DM, Szabo AZ, Ahad AB, et al. Influence of pulse sequence, polarity and amplitude on magnetic stimulation of human and porcine peripheral nerve. J Physiol (Lond) 1998;513:571-585. (Pubitemid 28562971)
43. Cohen D, Cuffin BN. Developing a more focal magnetic stimulator. Part 1: Some basic principles. J Clin Neurophysiol 1991;8:102-111.
44. Roth BJ, Cohen LG, Hallett M, Friauf W, Basser PJ. A theoretical calculation of the electric field induced by magnetic stimulation of a peripheral nerve. Muscle Nerve 1990;8:734-741. (Pubitemid 20238776)
45. Nagarajan SS, Durand D. A generalized cable equation for magnetic stimulation of axons. IEEE Trans Biomed Eng 1996;43:1-9.
46. Sobue G, Matsuoka Y, Mukai E, Takayanagi T, Sobue I. Pathology of myelinated fibers in cervical and lumbar ventral spinal roots in amyotrophic lateral sclerosis. J Neurol Sci 1981;50:413-421. (Pubitemid 11120782)
47. Sobue G, Sahashi K, Takahashi A, Matsuoka Y, Muroga T, Sobue I. Degenerating compartment and functioning compartments of motor neurons in ALS: possible process of motor neuron loss. Neurology 1983;33:654-657. (Pubitemid 13080464)
48. Abu-Shakra SR, Cornblath DR, Avila OL, Chaudhry V, Freimer M, Glass JD, et al. Conduction block in diabetic neuropathy. Muscle Nerve 1991;14:858-862.
49. Miyasaki H, Hasegawa O, Mori I, Matsumoto S, Arita T. Incidence of diabetic neuropathy which fulfills electrophysiologic criteria of CIDP [in Japanese]. No To Shinkei 1999;51:415-418. (Pubitemid 29320487)
50. Laughlin RS, Dyck PJ, Melton LJ, Leibson C, Ransom, Dyck PJB. Incidence and prevalence of CIDP and the association of diabetes mellitus. Neurology 2009;73:39-45.
51. Llewelyn JG, Tomlinson DR, Thomas PK. Diabetic neuropathies. In: Dyck PJ, Thomas PK, editors. Peripheral neuropathy. Vol.2. Philadelphia: Elsevier W.B. Saunders. 2005. p1951-1991.
52. Dyck PJ, Karnes JL, O'Brien P, Okazaki H, Lais A, Engelstad K. The spatial distribution of fiber loss in diabetic polyneuropathy suggests ischemia. Ann Neurol 1986;19:440-449. (Pubitemid 16116477)
53. Arnason BGW, Soloven B. Acute inflammatory demyelinating polyradiculoneuropathy. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Podulso JF, editors. Peripheral neuropathy. Vol. 2. Philadelphia: W.B. Saunders; 1993. p 1437-1497.
54. Olsson Y. Microenvironment of the peripheral nervous system under normal pathological conditions. Crit Rev Neurobiol 1990;5:265-311. (Pubitemid 20128523)
55. Saida T, Saida K, Silberberg DH, Brown MJ. Experimental allergic neuritis induced by galactocerebroside. Ann Neurol 1981;9:87-101. (Pubitemid 11120641)
56. Hahn AF, Feasby TE, Gilbert JJ. Blood-nerve barrier studies in experimental allergic neuritis. Arch Neuropathol (Berl) 1985;69:101-109. (Pubitemid 16242134)
57. Hahn AF, Feasby TE, Steele A, Lovgren DS, Berry J. Demyelination and axonal degeneration in Lewis rat experimental allergic neuritis depend on the myelin dosage. Lab Invest 1988;59:115-125.
58. Hahn AF, Hartung H-P, Dyck PJ. Chronic inflammatory demyelinating polyradiculopathy. In: Dyck PJ, Thomas PK, editors. Peripheral neuropathy. Vol. 2. Philadelphia: Elsevier W.B. Saunders; 2005. p 2221-2253.
59. Dyck PJ, Lais AC, Ohta M, Bastron JA, Okazaki H, Groover RV. Chronic inflammatory polyradiculoneuropathy. Mayo Clin Proc 1975;50:621-637.
60. Green LN, Herzog I, Aberfeld D. A case of hypertrophic interstitial neuritis coexisting with dementia and cerebellar degeneration. J Neuropathol Exp Neurol 1956;24:682-689.
61. Harris W, Newcomb WD. A case of relapsing interstitial hypertrophic polyneuritis. Brain 1929;52;108-116.
62. Matsuda M, Ikeda S-I, Sakurai S, Nezu A, Yanagisawa N, Inuzuka T. Hypertrophic neuritis due to chronic inflammatory demyelinaiting polyradiculopathy (CIDP): a postmortem pathological study. Muscle Nerve 1996;19:163-169. (Pubitemid 26038077)
63. Kaku DA, England JD, Sumner AJ. Distal accentuation of conduction slowing in polyneuropathy associated with antibodies to myelin-associated glycoprotein and sulphated glucuronyl paragloboside. Brain 1994;117:941-947. (Pubitemid 24350530)
64. Ritz M-F, Erne B, Ferracin F, Vital A, Vital C, Steck AJ. Anti-MAG IgM penetration into myelinated fibers correlates with the extent of myelin widening. Muscle Nerve 1999;22:1030-1037. (Pubitemid 29360246)
65. Sung J-Y, Kuwabara S, Ogawara K, Kanai K, Hattori T. Patterns of nerve conduction abnormalities in POEMS syndrome. Muscle Nerve 2002;26:189-193. (Pubitemid 34832800)
66. Sobue G, Doyu M, Watanabe M, Hayashi F, Mitsuma T. Extensive demyelinating change in the peripheral nerves of Crow-Fukase syndrome: a pathological study of one autopsied case. Acta Neuropathol 1992;84:171-177.
67. Vital C, Vital A, Ferrer X, Viallard JF, Pellegrin JL, et al. Crow-Fukase (POEMS) syndrome: a study of peripheral nerve biopsy in five new cases. J Periph Nerv Syst 2003;8:136-144. (Pubitemid 37075744)
68. Kimura J. F-wave velocity in the central segment of the median and ulnar nerves. A study in normal subjects and in patients with Charcot-Marie-Tooth disease. Neurology 1974;24:539-546.
69. Lewis RA, Sumner AJ. The electrodiagnostic distinctions between chronic familial and acquired demyelinative neuropathies. Neurology 1982;32:592-596. (Pubitemid 12119020)
70. Stanton M, Pannoni V, Lewis RA, Logigian EL, Naguib D, Shy ME, et al. Dispersion of compound muscle action potential in hereditary neuropathies and chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 2006;34:417-422. (Pubitemid 44506708)
71. Nodera H, Bostock H, Kuwabara S, Sakamoto T, Asamuma K, Jia-Ying S, et al. Nerve excitability properties in Charcot-Marie-Tooth disease type 1A. Brain 2004;127:203-211. (Pubitemid 38055359)